Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Macy's Inc (M) vs Koninklijke Philips NV (PHG) Price & Performance

Macy's IncTrade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

Macy's Inc vs Koninklijke Philips NV — how do they compare? Macy's Inc trades at $22.66 (market cap $5.95B), while Koninklijke Philips NV trades at $24.11 (market cap $23.52B). The key difference: Koninklijke Philips NV is far larger — about 4× Macy's Inc's market cap, and Koninklijke Philips NV pays the higher dividend (4.17%). Which is the better fit depends on your goals — on Pluang, investors hold Macy's Inc for 58 Days and Koninklijke Philips NV for 84 Days on average.

MPHG
Market Cap
$5.95B$23.52B
Volume
6,030,6441,635,069
Sector
Consumer CyclicalHealth
52-Week High
$26.21$32.91
52-Week Low
$16.51$23.81
Typical Hold Time
58 Days84 Days
Enterprise Value
$9.75B$29.87B
Dividend Yield
3.36%4.17%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Macy's Inc

Macy's (M) trades at $22.79, up 1.47% today, with a bullish technical signal from moving averages. The stock shows attractive valuation with a P/E of 8.35 and P/S of 0.27. Recent earnings have consistently beaten estimates, and the company's 'Bold New Chapter' strategy is driving digital and omnichannel growth, though revenue has trended down from $25.3B in 2022 to $23.0B in 2025.

The outlook is mixed; strong cash flow and a 3.5% dividend yield support income investors, but competitive pressures and uneven growth pose risks. Analyst consensus is a $24.25 price target with a Hold bias. Execution of the turnaround strategy remains key to unlocking value amid retail sector challenges.

Koninklijke Philips NV

PHG trades at $24.09, down 0.25% with a bearish technical signal. The company shows improving fundamentals with three consecutive quarterly EPS beats and a return to profitability in 2025 (net income $895M). Recent news highlights innovation in healthcare technology including new product launches and AI partnerships. Valuation metrics appear reasonable with P/E of 18.94 and P/S of 1.18.

PHG presents a mixed outlook with strong operational recovery but technical weakness. The investment case hinges on continued earnings momentum and successful execution of healthcare technology initiatives. Key risks include competitive pressures and potential cybersecurity vulnerabilities following recent hacking incidents. Analyst consensus leans neutral with 36% buy ratings versus 64% hold.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

M
100% Buy0% Sell
Avg holding period · 58 Days
PHG

No sentiment data available yet.

About Macy's Inc

Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.

Read more on M →

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG →